SYSMEX CORPORATION ADR
WKN: A12EJE | ISIN: US87184P1093 | Ticker-Symbol: 0YX0Siehe auch SYSMEX CORPORATION
Frankfurt
25.04.25
15:49 Uhr
15,400 Euro
0,000
0,00 %
0,00 %
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 15.04. | Macrium Software: Macrium Partners with Sysmex America to Reduce Medical Testing Downtime and Improve Patient Care | 211 | PR Newswire | British-based backup and recovery technology reduces labour costs by up to 75% while minimising downtime, creating a win-win for healthcare providers and patients.
MANCHESTER, England... ► Artikel lesen | |
| SYSMEX CORPORATION ADR Aktie jetzt für 0€ handeln | |||||
| 09.04. | Sysmex gründet Tochtergesellschaft in Kenia | 5 | Bionity.com | ||
| 01.04. | Sysmex Europe SE: Sysmex's PA-100 AST System: Revolutionising UTI diagnosis and treatment with precision | 300 | GlobeNewswire (Europe) | Sysmex's PA-100 AST System reduces the time for UTI diagnosis to 15 minutes and determines the optimal antibiotic within 30 minutes. A recently published budget impact analysis suggests potential healthcare... ► Artikel lesen | |
| 01.04. | EQS-Media: Sysmex Europe SE: Das PA-100 AST-System von Sysmex: Revolutionierung der Diagnose und Behandlung von Harnwegsinfektionen mit Präzision | 411 | EQS Group (DE) | EQS-Media / 01.04.2025 / 10:08 CET/CEST
Das System verkürzt die Zeit für die Diagnose von Harnwegsinfektionen auf nur 15 Minuten und bestimmt die optimalen Antibiotika innerhalb von 30... ► Artikel lesen | |
| 27.03. | Morgan Stanley lifts Sysmex stock rating to Overweight | 6 | Investing.com | ||
| 12.02. | Sysmex reports 9M results | 6 | Seeking Alpha | ||
| 07.11.24 | Sysmex GAAP EPS of ¥41.70, revenue of ¥242.48B | 24 | Seeking Alpha |
7 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| CARDINAL HEALTH | 118,90 | -0,34 % | What You Need To Know Ahead of Cardinal Health's Earnings Release | ||
| RESMED | 204,20 | -1,59 % | Guter Tag für ResMed-Aktionäre: Aktienkurs steigt deutlich (199,50 €) | Zu den großen Gewinnern an der Börse zählt heute die ResMed-Aktie . Das Wertpapier steigt deutlich. Eine Steigerung um 5,39 Prozent - mit diesem Wertanstieg gehört das Wertpapier von ResMed aktuell... ► Artikel lesen | |
| UNIDOC HEALTH | 0,185 | -9,73 % | UniDoc Health Corp.: UniDoc Announces LIFE Offering | THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, BC / ACCESS Newswire / April 4, 2025 / UniDoc Health Corp. (CSE:UDOC) ("UniDoc"... ► Artikel lesen | |
| ZIMMER BIOMET | 89,70 | +2,70 % | Zimmer Biomet Completes Acquisition Of Paragon 28 To Expand Foot & Ankle Portfolio | WASHINGTON (dpa-AFX) - Zimmer Biomet Holdings, Inc. (ZBH) Monday announced that it has finalized its acquisition of Paragon 28, a company specializing in foot and ankle orthopedic devices. The... ► Artikel lesen | |
| CO-DIAGNOSTICS | 0,320 | +1,91 % | Co-Diagnostics, Inc. Reports Full Year 2024 Financial Results |
SALT LAKE CITY, March 27, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the... ► Artikel lesen | |
| CLARIANE | 3,508 | -7,54 % | Clariane I 2025 first-quarter revenue | Press release Revenue for the three months to 31 March 2025 rose by 4.8% on an organic basis, which equates to a 5.5% increase on a comparable number of days.All businesses and regions contributed... ► Artikel lesen | |
| IZOTROPIC | 0,160 | -3,04 % | Izotropic Corporation: Izotropic Engages International Communications Consultant, Grants Incentive Stock Options & RSUs to Key Personnel, Amends Promissory Note with Primary Lender | Vancouver, British Columbia and Sacramento, California--(Newsfile Corp. - April 2, 2025) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company"), a medical device... ► Artikel lesen | |
| INSPIREMD | 2,260 | -0,88 % | InspireMD Inc.: InspireMD to Announce First Quarter 2025 Financial Results | ||
| RESHAPE LIFESCIENCES | 0,361 | -5,20 % | ReShape Lifesciences Inc: ReShape Lifesciences Receives Notice of Allowance for Additional U.S. Patent Related to Its Proprietary Diabetes Neuromodulation Technology | Vagal Neuromodulation Offers a Novel Approach to Treating Type 2 Diabetes and Hypoglycemia Patent Enables Equivalent Efficacy with 10 times Lower Energy Consumption Than Current Device Fully Compatible... ► Artikel lesen | |
| ASTRANA HEALTH | 26,800 | -2,90 % | Astrana Health, Inc.: Astrana Health Announces Definitive Agreement to Acquire Certain Businesses and Assets of Prospect Health System | ALHAMBRA, Calif., Nov. 8, 2024 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:... ► Artikel lesen | |
| PANGENOMIC HEALTH | 0,121 | -3,20 % | XFRA NEW INSTRUMENTS AVAILABLE ON XETRA - 14.11.2024 | The following instruments on XETRA do have their first trading 14.11.2024 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 14.11.2024
Aktien
1 ID1000127707 Saratoga Investama Sedaya... ► Artikel lesen | |
| ORGANOGENESIS | 3,840 | -3,52 % | Organogenesis Holdings Inc.: Organogenesis Reports Positive Interim Analysis of Second Phase 3 Clinical Trial of ReNu for Knee Osteoarthritis | CANTON, Mass., Nov. 11, 2024 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization... ► Artikel lesen | |
| CATHETER PRECISION | 0,283 | -14,13 % | Catheter Precision to acquire late-stage heart failure treatment assets in development | ||
| CROSSJECT | 0,869 | -1,59 % | CROSSJECT reports financial results for 2024 | Press Release CROSSJECT reports financial results for 2024 Continued satisfactory production of regulatory batches with a view to filing in Q2 2025.Recruitment of Tony Tipton as Chief Operating Officer... ► Artikel lesen | |
| ORIOLA | 1,066 | 0,00 % | Oriola Corporation: Resolutions of the Annual General Meeting of Oriola Corporation - Combination of share classes and thereto related directed issuance of shares without payment approved | Oriola Corporation's Stock Exchange Release 2 April 2025 at 6:00 p.m.
Resolutions of the Annual General Meeting of Oriola Corporation - Combination of share classes and thereto related directed issuance... ► Artikel lesen |
SYSMEX CORPORATION ADR gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von 0,000 (0,00 %) liegt der Kurs bei 15,400 Euro. Beim derzeitigen Kurs ergibt sich, basierend auf einer gesamten Ausschüttung von 0,00 Euro in den vergangenen 12 Monaten, eine Dividendendrendite von 0,00 %.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu SYSMEX CORPORATION ADR finden Sie auf Wallstreet Online.
